<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.3'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//aviva-bio.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://aviva-bio.com/aviva-bios-ava-291-emerges-as-best-in-class-therapy-to-address-fda-identified-safety-concerns-of-testosterone-for-women/</loc>
  <lastmod>2026-10-12T14:56:51Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Aviva Bio</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Aviva Bio&amp;#039;s AVA-291 Emerges as Best-in-Class Therapy to Address FDA-Identified Safety Concerns of Testosterone for Women</news:title>
   <news:publication_date>2026-10-12T14:51:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
